Juárez-López MLA, Solano-Silva MN, Fragoso-Ríos R, Murrieta-Pruneda F

Language: Spanish
References: 27
Page: 132-135
PDF size: 349.41 Kb.

ABSTRACT

Background: Pediatric patients with acute lymphoblastic leukemia (ALL) usually develop oral manifestations due to the disease itself, as well as side effects of chemotherapy that severely affect their health and quality of life. The aim of this paperis to determine the prevalence of oral diseases in pediatric all patients with and without chemotherapy and its relation to the different phases of chemotherapy.
Methods: A cross-sectional observational study was conducted in 103 pediatric patients with all between 3-15 years. They were classified into groups: without chemotherapy and with chemotherapy at phase of consolidation, enhancement, maintenance and monitoring. Clinical diagnosis was performed and gingival inflammation index (IMPA) and caries criteria (dmf and DMF) were applied.
Results: The prevalence oral manifestations in the chemotherapy group were mucositis (98%), ulcers (90%), gingivitis (86%) and candidiasis (78%). The induction phase related with mucositis: RM = 7.6, 95%CI: 4.4-13, p = 0.0001; candidiasis: OR = 103, 95%CI: 13.0-818, p = 0.0001; gingivitis: OR = 16.2, 95%CI: 5.5-47, p = 0.0001; ulcers OR = 61.5, 95%CI: 8.7-432, p = 0.0001.
Conclusions: The frequency and severity of oral diseases was hight and associated with the induction phase of chemotherapy, altering the overall nutrition and health of children.

REFERENCES

1. Rivera R. El niño con cáncer. Los padecimientos más comunes para el médico no especialista. México: Editores de Textos Mexicanos; 2007.

2. Little J. Epidemiology of childhood cancer. Lyon: International Agency for Research on Cancer. Geneva, Switzerland: World Health Organization; 1999.

3. Reyes C, Gallegos F, García M, Bustos M, Nambo M, Silva A. Prevención, tratamiento y rehabilitación en el paciente oncológico. Importancia del tratamiento integral y multidisciplinario. Rev ADM. 2010;67(5):210-216.

4. Muñoz-Hoyos A, Del Moral-Romero E, Uberos-Fernández J. Oncología Infantil. En serie Formación continuada en Pediatría. Serie Monográfica. Granada, España: Formación Alcalá; 2001.

5. Stephen TS, Fey EG. Oral complications of cancer therapy. Oncology; 2002;16(5):680-6.

6. Brown RT. Comprehensive handbook of childhood. Cancer and sickle cell disease. A biopsychosocial aproach. New York, NY: Oxford University press; 2006.

7. Pizzo PA, Poplack DG. Principles and practice of pediatric oncology. Philadelphia, PA: Lippincott Williams & Wilkins; 2011.

8. Quasso L, Scipioni C, Pavesi L, Calzavara-Mantovani D, Perea-García MA, Bascones-Martínez A. Complicaciones periodontales en las leucemias en edad pediátrica. Av Periodon Implantol. 2005;17(2):55-68.

9. Díaz-Guzman L, Castellanos J, Gay O. Series en Medicina Bucal IV. Manejo odontológico del paciente que recibe quimioterapia. Rev ADM. 2003;60(5):198-201.

10. Chin EA. A brief overview of the oral complications in pediatric oncology patients and suggested management strategies. J. Dent Child. 1998;65(6):468-73.

11. World Health Organization. Oral Health Surveys: Basic methods 3rd. Geneva, Switzerland: World Health Organization; 1997.

12. Murrieta-Pruneda F, Juárez-López MLA. Índices epidemiológicos de morbilidad bucal en México. Distrito Federal, México: FES Zaragoza. UNAM; 2006.

13. Cheng KK, Goggins WB. Risk Factors for oral mucositis in children undergoing chemotherapy: A matched case-control study. J Oral Oncol. 2008;44:1019-25.

14. Barasch A, Peterson D. Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions. Oral Oncol. 2003;39(2):91-100.

15. Fernbach J, Vietti J. Clinical pediatric oncology. 4ta Edición. Boston, Massachusetts: Mosby Year Book; 1991. p. 173-329.

16. Karis KF. Incidence and risk factors of oral mucositis in 2 paediatric and adolescent patients undergoing chemotherapy. Oral Oncol. 2011;47:153-162.

17. De la Teja-Angeles E, Niembro-Zermeño A, Durán- Gutierrez A. Mucositis bucal. Acta Pediatr Mex. 2011;32(4):255-256.

18. Kalifa C. Cancer in children. Clinical management. International Society of Paediatric Oncology. 4ta Edición. New York, NY: Oxford University Press; 1998. p. 99-115.

19. Cabrerizo M, Oñate R. Aspectos odontoestomatológicos en oncología infantil. Med Oral Patol Oral Cir Bucal. 2005;10:41-47.

20. Javed F, Utreja A, Bello-Correa FO, Al-Askar M, Hudieb M, Qayyum F, Al-Rasheed A, Almas K, Al-Hezaimi K. Oral health status in children with acute lymphoblastic leukemia. Crit Rev Oncol Hematol. 2012;83(3):303-9.

21. Hegde AM, Joshi S, Rai K, Shetty S. Evaluation of salivary sialic acid levels in acute lymphoblastic leukemic children and its correlation with dental caries experience. J Clin Pediatr Dent. 2013;37(3):309-13.

22. Lauritano D, Petruzzi M. Decayed, missing and filled teeth index and dental anomalies in long-term survivors leukaemic children: A prospective con¬trolled study. Med Oral Patol Oral Cir Bucal. 2012;17(6):977-80.

23. Michelet M. Caries and periodontal disease in cancer suvivors. Evid Based Dent. 2012;13(3):70-3.

24. Kinirons MJ, Fleming P, Boyd D. Dental caries experience in children in remission from acute lymphoblastic leukaemia in relation to the duration of treatment and the period of time in remission. Int J Paediatr Dent. 1995;5(3):169-72.

25. Wilberg P, Kanellopoulos A, Ruud E, Hjermstad MJ, Fosså SD, Herlofson BB. Dental abnormalities after chemotherapy in long-term survivors of childhood acute lymphoblastic leukemia 7-40 years after diagnosis. Support Care Cancer. 2016;24(4):1497-506.

26. Casariego ZJ. La participación del odontólogo en el control del cáncer oral: Manejo en la Prevención, tratamiento y rehabilitación. Avances en Odontoestomatol. 2009;25(5):265-85.

27. Lanza-Echeveste D. Tratamiento odontológico integral del paciente oncológico: Parte I. Odontoestomatología. 2011;13(17):14-25.